HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia.

AuthorsE Longeval, D Ganglji, P Stryckmans, Y Kenis
JournalCancer chemotherapy reports (Cancer Chemother Rep) 1975 Nov-Dec Vol. 59 Issue 6 Pg. 1173-5 ISSN: 0069-0112 [Print] United States
PMID769961 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • mitoclomine
  • 1-Naphthylamine
Topics
  • 1-Naphthylamine (adverse effects, analogs & derivatives, therapeutic use)
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Blood Cell Count
  • Clinical Trials as Topic
  • Female
  • Humans
  • Leukemia, Lymphoid (drug therapy)
  • Male
  • Middle Aged
  • Nitrogen Mustard Compounds (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: